Sign In
Buy CCXI
$13.86
-0.140 (-1.00%)
At Close: Jul 31, 2026
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
04:40pm, Saturday, 12'th Jun 2021
New York, New York--(Newsfile Corp. - June 12, 2021) - Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI). Such investo
LOS ANGELES--(BUSINESS WIRE)---- $CCXI #CCXI--SHAREHOLDER ACTION REMINDER: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc.
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against ChemoCentryx, Inc. (CCXI)
01:00pm, Friday, 11'th Jun 2021
LOS ANGELES, June 11, 2021 /PRNewswire/ -- Glancy Prongay & Murray LLP ("GPM") reminds investors of the upcoming July 6, 2021 deadline to file a lead plaintiff motion in the class action filed on
New York, New York--(Newsfile Corp. - June 11, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of ChemoCentryx, Inc. (NASDAQ: CCXI) between Novembe
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against ChemoCentryx, Inc.
11:35am, Friday, 11'th Jun 2021
RADNOR, Pa., June 11, 2021 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP reminds ChemoCentryx, Inc. (NASDAQ: CCXI) ("ChemoCentryx") investors that a securities fraud class acti
CCXI Stock: 12 Things to Know About ChemoCentryx as Shares Surge Today
11:15am, Friday, 11'th Jun 2021
ChemoCentryx (CCXI) stock is on the rise Friday as investors anticipate one of its treatments getting approval from the FDA. The post CCXI Stock: 12 Things to Know About ChemoCentryx as Shares Surge T
Los Angeles, California--(Newsfile Corp. - June 11, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ChemoCentryx, Inc. (
New York, New York--(Newsfile Corp. - June 11, 2021) - The Klein Law Firm announces that a class action complaint has been filed on behalf of shareholders of ChemoCentryx, Inc. (NASDAQ: CCXI) alleging
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ChemoCentryx, Inc. - CCXI
04:00am, Friday, 11'th Jun 2021
NEW YORK, June 11, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of ChemoCentryx, Inc. ("ChemoCentryx" or the "Company") (NASDAQ: CCXI). Such investors are ad
New Orleans, Louisiana--(Newsfile Corp. - June 10, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have u
New York, New York--(Newsfile Corp. - June 10, 2021) - The following statement is being issued by Levi & Korsinsky, LLP:To: All persons or entities who purchased or otherwise acquired securities of
LOS ANGELES--(BUSINESS WIRE)---- $CCXI #CCXI--SHAREHOLDER ACTION ALERT: The Schall Law Firm Reminds Investors of a Class Action Lawsuit Against ChemoCentryx, Inc.
SAN FRANCISCO, June 10, 2021 /PRNewswire/ -- Hagens Berman urges ChemoCentryx, Inc. (NASDAQ: CCXI) investors with significant losses to submit your losses now. A securities fraud class action is p
Los Angeles, California--(Newsfile Corp. - June 10, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against ChemoCentryx, Inc. (
CCXI LAWSUIT: The Law Offices of Vincent Wong Notify Investors of a Class Action Lawsuit Involving ChemoCentryx, Inc.
01:32pm, Wednesday, 09'th Jun 2021
New York, New York--(Newsfile Corp. - June 9, 2021) - The Law Offices of Vincent Wong announce that a class action lawsuit has commenced in the on behalf of investors who purchased ChemoCentryx, Inc.
